ANALYSIS OF THE USE OF MOBILE APPLICATIONS BY FOREIGN AND UKRAINIAN PHARMACIES WITHIN THE CONCEPT OF HOLISTIC MARKETING

Nataliia Sakhnatska; Nataliia Aliekperova

doi:10.32345/USMYJ.127(4).2021.84-91

Nataliia Sakhnatska Assistant of the Department of Organization and Economics of Pharmacy, Bogomolets National Medical University, Kyiv, Ukraine.
Nataliia Aliekperova Candidate of Pharmaceutical Sciences, Associate Professor of the Department of Organization and Economics of Pharmacy, Bogomolets National Medical University, Kyiv, Ukraine.

DOI: https://doi.org/10.32345/USMYJ.127(4).2021.84-91

Keywords: telemedicine, drug evaluation, mobile application, pharmaceutical preparations, pharmacy.

Abstract

digitalization of the pharmaceutical sector requires the use of modern marketing approaches to provide pharmacies with quality and safe pharmaceutical care within the holistic concept of marketing management. A promising direction of digital transformation of the retail market of medicines is the introduction of special mobile applications in the activities of pharmacies, which become a safe and accessible platform for the sale of medicines to the population.

The main purpose of the study is to exercise the analysis of the features of pharmaceutical services provision using mobile applications to foreign and Ukrainian pharmacy chains.

The study is based on the use of content analysis, analysis of electronic resources, system, and logical analysis, as well as of the modeling method.

As the objects of the study, American pharmacy chains CVS Pharmacy and Walgreens, British Boots, and Lloyds Pharmacy were selected, as well as 10 pharmacy chains in Ukraine in terms of turnover in January-October 2020.

It is revealed that the leading world leaders in the retail market of medicines have been using this digital tool in their marketing activities for a long time. Unlike domestic pharmacies, applications of foreign pharmacies additionally provide such services as online registration for testing and vaccination against COVID-19, additional opportunities for the visually impaired, drug disposal, and others. Among the studied Ukrainian pharmacy chains by market share, only a half have mobile applications with various functions, among the most developed mobile applications are “Like” from LLC “Apteka-Magnolia” (“Pharmacy-Magnolia”), "Pharmacy 911" and “Apteka Dobroho Dnia” (“Good Afternoon Pharmacy”).

An integrated model of a mobile application of a modern pharmacy has been developed, aimed at effective interaction of all necessary functions to provide the population with high-quality, convenient, and available pharmaceutical care. Promising areas of further research are the justification of the feasibility of using certain functions of mobile applications, as well as other digital tools, such as pharmacy websites, social media pages within the concept of holistic marketing.

The results of the study conducted may be useful to specialists in the pharmaceutical industry for use in practical pharmacy.

References

Berghuis, A. M. S., Koffijberg, H., Terstappen, L. W. M. M., Sleijfer, S., & IJzerman, M. J. (2018). Evidence on the cost of breast cancer drugs is required for rational decision making. ecancermedicalscience, 12.

Cardoso, F., Costa, A., Norton, L., Senkus, E., Aapro, M., Andre, F., ... & Winer, E. (2014). ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2). The Breast, 23(5), 489-502.

Kamińska, M., Ciszewski, T., Łopacka-Szatan, K., Miotła, P., & Starosławska, E. (2015). Breast cancer risk factors. Przeglad menopauzalny= Menopause review, 14(3), 196.

National Collaborating Centre for Cancer (UK. (2009). Advanced breast cancer: diagnosis and treatment.

National Collaborating Centre for Cancer (UK). (2009). Early and Locally Advanced Breast Cancer: Diagnosis and Treatment. National Collaborating Centre for Cancer (UK).

National Collaborating Centre for Primary Care (UK). (2006). Familial Breast Cancer: The Classification and Care of Women at Risk of Familial Breast Cancer in Primary, Secondary and Tertiary Care: Update. Royal College of General Practitioners (UK).

National Institute for Health and Care Excellence. Familial breast cancer: classification and care of people at risk of familial breast cancer and management of breast cancer and related risks in people with a family history of breast cancer. (Clinical guideline 164.) 2013.

Nemchenko, A. S. (2009). Clinicaland economical analysis of pharmaceutical providing of the patients with breast cancer/Nemchenko AS, Podgaynaya MV. Вісник фармації, (1), 50-53.

Order of the Ministry of Health of Ukraine dated 30.06.2015 №396 "On approval and implementation of medical and technological documents for the standardization of medical care for breast cancer"

Senkus, E., Kyriakides, S., Ohno, S., Penault-Llorca, F., Poortmans, P., Rutgers, E., ... & Cardoso, F. (2015). Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of oncology, 26, v8-v30.

World Health Organization. International Agency for Research on Cancer